Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
  • About Us
    • About the Ochsner Journal
    • Editorial Board
  • More
    • Alerts
    • Feedback
  • Other Publications
    • Ochsner Journal Blog

User menu

  • My alerts
  • Log in

Search

  • Advanced search
Ochsner Journal
  • Other Publications
    • Ochsner Journal Blog
  • My alerts
  • Log in
Ochsner Journal

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
  • About Us
    • About the Ochsner Journal
    • Editorial Board
  • More
    • Alerts
    • Feedback
Case ReportCase Reports

Dexmedetomidine for Anterior Mediastinal Mass Computed Tomography-Guided Biopsy: A Case Series

Dominic S. Carollo, Sophie Pestieau and Richard Bosco
Ochsner Journal December 2013, 13 (4) 541-543;
Dominic S. Carollo
*Department of Anesthesiology and Pain Management, Ochsner Clinic Foundation, New Orleans, LA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sophie Pestieau
†Division of Anesthesiology and Pain Medicine, Children's National Medical Center, Washington, DC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard Bosco
†Division of Anesthesiology and Pain Medicine, Children's National Medical Center, Washington, DC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

Abstract

Background Sedation of children undergoing biopsies of anterior mediastinal masses can be challenging because of the absolute necessity of ensuring minimal smooth muscle relaxation and preventing airway collapse. Furthermore, positive pressure ventilation may be difficult or impossible and may also pose the additional risks of hemodynamic compromise in the pediatric patient.

Case Reports We present a case series of 3 children who were successfully sedated for computed tomography (CT)-guided mediastinal biopsies with dexmedetomidine.

Conclusion Dexmedetomidine, a selective alpha-2 adrenoreceptor agonist that maintains the smooth musculature of the pediatric airway, provides the ability to sustain spontaneous ventilation in patients with airway compression. Dexmedetomidine is a safe, reliable anesthetic for biopsy of children with anterior mediastinal masses.

Keywords
  • Adrenergic alpha-2 receptor agonists
  • dexmedetomidine
  • mediastinal neoplasms

INTRODUCTION

Children with anterior mediastinal masses (AMM) can be extremely challenging for the pediatric anesthesiologist. Maintenance of adequate airway architecture with minimal smooth muscle relaxation and prevention of collapse is vital. Compression of the mediastinal structures by bulky masses may make positive pressure ventilation difficult or impossible and may also pose additional risks of hemodynamic compromise in this patient population. Therefore, spontaneous ventilation is considered essential for safe anesthesia administration.

Dexmedetomidine, a highly selective alpha-2 agonist that has both sedative and analgesic properties,1–4 is a suitable sedation agent for radiologic imaging studies.5,6 Hemodynamic effects in adults and children are modest.7 A recent report of 2 adults with significant AMMs undergoing sedation showed that dexmedetomidine allows for significantly stimulating procedures to be safely performed.8 We present a case series of pediatric patients who were successfully sedated for computed tomography (CT)-guided mediastinal biopsies.

CASE 1

A 50.2 kg, 13-year-old male had a history of a neck mass for 2 months. Despite his compromised borderline respiratory status, he tolerated an uneventful CT scan of the chest that showed a large 10.6 × 6.9 cm mass compressing the superior vena cava and trachea. After appropriate further workup—including echocardiogram and consultation with the oncology, surgery, and interventional radiology services—the decision was made to proceed with a sedated CT-guided biopsy for diagnostic purposes. The patient was positioned supine on the CT table, a nasal cannula was placed, and the patient continued spontaneous ventilation on 28% FiO2. After intravenous (IV) administration of 1 mg midazolam, dexmedetomidine was gradually bolused IV 3 times in doses of 0.5 mcg/kg over 5 minutes until the patient achieved an adequate level of sedation. Local anesthesia was infiltrated into the chest wall, and the biopsy was performed uneventfully with the patient maintaining spontaneous ventilation throughout. The pathology report showed stage IIA Hodgkin lymphoma for which the patient underwent chemotherapy and had a complete remission.

CASE 2

A 44.6 kg, 12-year-old male had a history of chest pain for 2 weeks. The patient denied dyspnea or orthopnea. A CT scan revealed a 9.8 × 8 × 10.6 cm AMM that was completely obstructing the left pulmonary artery and left mainstem bronchus. For his biopsy, the patient was placed supine on the CT table with oxygen support of 2 L via nasal cannula. Midazolam 1 mg was given twice IV for anxiolysis. Two 5-minute boluses of dexmedetomidine, 0.25 mcg/kg and 0.5 mcg/kg, and a ketamine 0.5 mg/kg bolus were subsequently given IV to ensure adequate analgesia and sedation before the procedure began. A local anesthetic (1% lidocaine) was infiltrated into the chest wall, and the biopsy was performed without complications. The pathology report was consistent with T-cell lymphoma for which the patient is currently in remission after chemotherapy.

CASE 3

An AMM measuring 6.0 × 7.0 × 7.6 cm (Figure 1) was found in an 8.7 kg, 23-month-old female during the workup for her failure to thrive. The family noted that the patient was able to lie flat at home with no difficulty or alterations in breathing. Because she was slightly agitated upon her arrival into the radiologic suite, she was given ketamine 1 mg/kg IV, followed by midazolam 1 mg IV, slowly titrated to allow her to calmly lie supine on the CT table for her CT-guided AMM biopsy. The parents were then escorted out of the radiologic suite. A dexmedetomidine infusion was started at 0.7 mcg/kg/h and raised to 1 mcg/kg/h to induce deep sedation for the infiltration of a local anesthetic (1% lidocaine). Although the biopsy was uneventful, a rather large pneumothorax (Figure 2) required the placement of 2 pig-tailed catheters postbiopsy. No hemodynamic changes were noted, and the patient tolerated this second procedure well. The chest catheters were removed 2 days later, and the pathology report was consistent with benign thymic hyperplasia. The tumor was completely removed 10 days later without complications.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Computed tomography scan showing a bulky anterior mediastinal mass compressing the left bronchus of the patient described in case 3.

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

Computed tomography (CT) scan showing a left pneumothorax following CT-guided biopsy of the anterior mediastinal mass in the patient described in case 3.

DISCUSSION

Dexmedetomidine, a selective alpha-2 adrenoreceptor agonist, is a sedative with growing experience in the pediatric population. Besides its analgesic and sedative properties, dexmedetomidine has a minimal impact on respiratory parameters, making it potentially an ideal drug for patients with respiratory compromise. To achieve an adequate level of deep sedation, the 3 patients in this case series required a combination of dexmedetomidine and midazolam, with the addition of ketamine for the third patient. Anesthetic depth for each of the patients was maintained with an infusion of dexmedetomidine. All patients received injection of subcutaneous lidocaine and underwent the CT-guided biopsy uneventfully. The patient described in case 3 developed postbiopsy pneumothoraces but never developed signs of a tension pneumothorax, in part because the child was breathing spontaneously and positive pressure was not utilized for ventilation. Finally none of the children developed hypotension or bradycardia. The noninfant patients woke up in the recovery room with no recollection of the biopsy.

In 2 recent adult cases, dexmedetomidine was used as the maintenance anesthetic for bronchoscopic insertion of bronchial stents.8 This adult population is similar to the pediatric AMM population that requires a tissue biopsy to determine the definitive medical or surgical management. Airway obstruction in AMM patients undergoing general anesthesia is dangerous for 3 reasons: (1) relaxation of the smooth muscle surrounding the trachea under general anesthesia can lead to collapse of the trachea; (2) lung volumes are reduced in patients with AMMs; and (3) loss of spontaneous diaphragm movement decreases the transpleural pressure gradient, leading to a decrease in airway diameter.8,9 Preventing these complications requires a detailed anesthetic plan that allows for spontaneous ventilation while keeping lung volumes elevated, even in the supine position, and that would not cause relaxation of the smooth muscle of the trachea. Recently, upper airway morphology in spontaneously breathing healthy children undergoing magnetic resonance imaging (MRI) has been studied.10 Clinically modest dynamic and static changes were seen in the airway with increasing doses of dexmedetomidine. The authors concluded that the airway changes are small and do not appear to be associated with clinical signs of airway obstruction.10 Another report showed no evidence of airway obstruction in patients with obstructive sleep apnea and trisomy 21 who had MRI evaluations using dexmedetomidine and ketamine.11

CONCLUSION

Our case series shows that by maintaining airway smooth muscle tone and spontaneous ventilation, dexmedetomidine is a safe, reliable anesthetic for biopsy of children with AMMs. Dexmedetomidine is ideally suited for providing an adequate level of sedation for many types of procedures. This novel approach to the pediatric patient with an AMM demonstrates another use for this medication in pediatric anesthesia.

This article meets the Accreditation Council for Graduate Medical Education and the American Board of Medical Specialties Maintenance of Certification competencies for Patient Care and Medical Knowledge.

Footnotes

  • The authors have no financial or proprietary interest in the subject matter of this article.

  • © Academic Division of Ochsner Clinic Foundation

REFERENCES

  1. ↵
    1. Venn RM,
    2. Hell J,
    3. Grounds RM
    (2000) Respiratory effects of dexmedetomidine in the surgical patient requiring intensive care. Crit Care 4(5):302–308, pmid:11056756, Epub 2000 Jul 31.
    OpenUrlCrossRefPubMed
    1. Carollo DS,
    2. Nossaman BD,
    3. Ramadhyani U
    (8, 2008) Dexmedetomidine: a review of clinical applications. Curr Opin Anaesthesiol 21(4):457–461, pmid:18660652.
    OpenUrlCrossRefPubMed
    1. Kauppila T,
    2. Kemppainen P,
    3. Tanila H,
    4. Pertovaara A
    (1, 1991) Effect of systemic medetomidine, an alpha 2 adrenoceptor agonist, on experimental pain in humans. Anesthesiology 74(1):3–8, pmid:1670912.
    OpenUrlCrossRefPubMed
  2. ↵
    1. Pestieau SR,
    2. Quezado ZM,
    3. Johnson YJ,
    4. et al.
    (11, 2011) The effect of dexmedetomidine during myringotomy and pressure-equalizing tube placement in children. Paedriatr Anaesth 21(11):1128–1135.
    OpenUrl
  3. ↵
    1. Mason KP,
    2. Zgleszewski SE,
    3. Dearden JL,
    4. et al.
    (7, 2006) Dexmedetomidine for pediatric sedation for computed tomography imaging studies. Anesth Analg 103(1):57–62, pmid:16790626, table of contents.
    OpenUrlCrossRefPubMed
  4. ↵
    1. Hall JE,
    2. Uhrich TD,
    3. Barney JA,
    4. Arain SR,
    5. Ebert TJ
    (3, 2000) Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions. Anesth Analg 90(3):699–705, pmid:10702460.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Mason KP,
    2. Zgleszewski SE,
    3. Prescilla R,
    4. Fontaine PJ,
    5. Zurakowski D
    (5, 2008) Hemodynamic effects of dexmedetomidine sedation for CT imaging studies. Paediatr Anaesth 18(5):393–402, pmid:18363628, Epub 2008 Mar 18.
    OpenUrlCrossRefPubMed
  6. ↵
    1. Abdelmalak B,
    2. Marcanthony N,
    3. Abdelmalak J,
    4. Machuzak MS,
    5. Gildea TR,
    6. Doyle DJ
    (8, 2010) Dexmedetomidine for anesthetic management of anterior mediastinal mass. J Anesth 24(4):607–610, pmid:20454810, Epub 2010 May 8.
    OpenUrlCrossRefPubMed
  7. ↵
    1. Neuman GG,
    2. Weingarten AE,
    3. Abramowitz RM,
    4. Kushins LG,
    5. Abramson AL,
    6. Ladner W
    (2, 1984) The anesthetic management of the patient with an anterior mediastinal mass. Anesthesiology 60(2):144–147, pmid:6546480.
    OpenUrlCrossRefPubMed
  8. ↵
    1. Mahmoud M,
    2. Radhakrishman R,
    3. Gunter J,
    4. et al.
    (6, 2010) Effect of increasing depth of dexmedetomidine anesthesia on upper airway morphology in children. Paediatr Anaesth 20(6):506–515, pmid:20412456, Epub 2010 Apr 12.
    OpenUrlCrossRefPubMed
  9. ↵
    1. Luscri N,
    2. Tobias JD
    (7, 2006) Monitored anesthesia care with a combination of ketamine and dexmedetomidine during magnetic resonance imaging in three children with trisomy 21 and obstructive sleep apnea. Paediatr Anaesth 16(7):782–786, pmid:16879522.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

Ochsner Journal
Vol. 13, Issue 4
Dec 2013
  • Table of Contents
  • Index by author
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on Ochsner Journal.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Dexmedetomidine for Anterior Mediastinal Mass Computed Tomography-Guided Biopsy: A Case Series
(Your Name) has sent you a message from Ochsner Journal
(Your Name) thought you would like to see the Ochsner Journal web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Dexmedetomidine for Anterior Mediastinal Mass Computed Tomography-Guided Biopsy: A Case Series
Dominic S. Carollo, Sophie Pestieau, Richard Bosco
Ochsner Journal Dec 2013, 13 (4) 541-543;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Dexmedetomidine for Anterior Mediastinal Mass Computed Tomography-Guided Biopsy: A Case Series
Dominic S. Carollo, Sophie Pestieau, Richard Bosco
Ochsner Journal Dec 2013, 13 (4) 541-543;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • INTRODUCTION
    • CASE 1
    • CASE 2
    • CASE 3
    • DISCUSSION
    • CONCLUSION
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Cited By...

  • Recent Publications by Ochsner Authors: October 2013 - March 2014
  • Google Scholar

More in this TOC Section

  • Propofol Infusion Syndrome or Not? A Case Report
  • Recurrent Angiomatoid Fibrous Histiocytoma: A Case Report and Review of the Literature
  • Late Recurrence of Light Chain Deposition Disease after Kidney Transplantation Treated with Bortezomib: A Case Report
Show more Case Reports

Similar Articles

Keywords

  • Adrenergic alpha-2 receptor agonists
  • dexmedetomidine
  • mediastinal neoplasms

Current Post at the Blog

American Association for the Advancement of Science Surveys Scientists About Article Publishing Charges—And Uncovers More Problems

Our Content

  • Home
  • Current Issue
  • Ahead of Print
  • Archive
  • Featured Contributors
  • Ochsner Journal Blog
  • Archive at PubMed Central

Information & Forms

  • Instructions for Authors
  • Instructions for Reviewers
  • Submission Checklist
  • FAQ
  • License for Publishing-Author Attestation
  • Patient Consent Form
  • Submit a Manuscript

Services & Contacts

  • Permissions
  • Sign up for our electronic table of contents
  • Feedback Form
  • Contact Us

About Us

  • Editorial Board
  • About the Ochsner Journal
  • Ochsner Health
  • University of Queensland-Ochsner Clinical School
  • Alliance of Independent Academic Medical Centers

© 2023 Ochsner Clinic Foundation

Powered by HighWire